Newcastle Disease Virus LaSota Strain Kills Human Pancreatic Cancer Cells in Vitro with High Selectivity. Jan 2012 - JOP; 13(1):1590-8577 [PMID:22233946] [Walter RJ] [Attar BM] [Rafiq A] [Tejaswi S] [Delimata M]
Heat shock protein 27 as a prognostic and predictive biomarker in pancreatic ductal adenocarcinoma. Oct 2011 - :1582-4934 [PMID:22004109] [Schäfer C] [Seeliger H] [Bader DC] [Assmann G] [Buchner D] [Guo Y] [Ziesch A] [Palagyi A] [Ochs S] [Laubender RP] [Jung A] [De Toni EN] [Kirchner T] [Göke B] [Bruns C] [Gallmeier E]
Regional Hyperthermia Combined with Chemoradiotherapy in Primary or Recurrent Locally Advanced Pancreatic Cancer : An Open-Label Comparative Cohort Trial. Sep 2011 - :1439-099X [PMID:21932025] [Maluta S] [Schaffer M] [Pioli F] [Dall'oglio S] [Pasetto S] [Schaffer PM] [Weber B] [Giri MG]
Current immunotherapeutic approaches in pancreatic cancer. Sep 2011 - Clin. Dev. Immunol.; 2011:1740-2530 [PMID:21922022] [Koido S] [Homma S] [Takahara A] [Namiki Y] [Tsukinaga S] [Mitobe J] [Odahara S] [Yukawa T] [Matsudaira H] [Nagatsuma K] [Uchiyama K] [Satoh K] [Ito M] [Komita H] [Arakawa H] [Ohkusa T] [Gong J] [Tajiri H]
Clinical and Immunologic Evaluation of Dendritic Cell-Based Immunotherapy in Combination With Gemcitabine and/or S-1 in Patients With Advanced Pancreatic Carcinoma. Jul 2011 - :1536-4828 [PMID:21792083] [Kimura Y] [Tsukada J] [Tomoda T] [Takahashi H] [Imai K] [Shimamura K] [Sunamura M] [Yonemitsu Y] [Shimodaira S] [Koido S] [Homma S] [Okamoto M]
Hyperthermia potentiates oncolytic herpes viral killing of pancreatic cancer through a heat shock protein pathway. Jul 2010 - Surgery; 148(2):1532-7361 [PMID:20633729] [Eisenberg DP] [Carpenter SG] [Adusumilli PS] [Chan MK] [Hendershott KJ] [Yu Z] [Fong Y]
Impact of surgery and chemotherapy on cellular immunity in pancreatic carcinoma patients in view of an integration of standard cancer treatment with immunotherapy. May 2009 - Int. J. Oncol.; 34(6):1019-6439 [PMID:19424589] [Bellone G] [Novarino A] [Vizio B] [Brondino G] [Addeo A] [Prati A] [Giacobino A] [Campra D] [Fronda GR] [Ciuffreda L]
A combination therapy of gemcitabine with immunotherapy for patients with inoperable locally advanced pancreatic cancer. Mar 2009 - Pancreas; 38(3):1536-4828 [PMID:19276867] [Hirooka Y] [Itoh A] [Kawashima H] [Hara K] [Nonogaki K] [Kasugai T] [Ohno E] [Ishikawa T] [Matsubara H] [Ishigami M] [Katano Y] [Ohmiya N] [Niwa Y] [Yamamoto K] [Kaneko T] [Nieda M] [Yokokawa K] [Goto H]
A phase I/II study of a MUC1 peptide pulsed autologous dendritic cell vaccine as adjuvant therapy in patients with resected pancreatic and biliary tumors. Mar 2009 - Cancer Ther; 6(B):1543-9143 [PMID:19129927] [Lepisto AJ] [Moser AJ] [Zeh H] [Lee K] [Bartlett D] [McKolanis JR] [Geller BA] [Schmotzer A] [Potter DP] [Whiteside T] [Finn OJ] [Ramanathan RK]
Countering tumor-induced immunosuppression during immunotherapy for pancreatic cancer. Feb 2009 - Expert Opin Biol Ther; 9(3):1744-7682 [PMID:19216622] [Morse MA] [Hall JR] [Plate JM]
[Specific immune against pancreatic cancer induced by dendritic cells pulsed with mutant K-ras peptide] Dec 2008 - Zhonghua Yi Xue Za Zhi; 88(28):0376-2491 [PMID:19062734] [Yang B] [He Y] [Sun DL] [Zou Y] [Qin XH] [Huang BH]
Biological approaches to therapy of pancreatic cancer. Oct 2008 - Pancreatology; 8(4-5):1424-3911 [PMID:18724071] [Wong HH] [Lemoine NR]
Immunotherapy of pancreatic carcinoma. Jun 2008 - Curr Opin Investig Drugs; 9(6):1472-4472 [PMID:18516755] [Märten A] [Büchler MW]
Immunotherapy of pancreatic carcinoma. May 2008 - ; 3(2):1574-8871 [PMID:18474022] [Märten A]
Adoptive immunotherapy for pancreatic cancer using MUC1 peptide-pulsed dendritic cells and activated T lymphocytes. Apr 2008 - Anticancer Res.; 28(1B):0250-7005 [PMID:18383873] [Kondo H] [Hazama S] [Kawaoka T] [Yoshino S] [Yoshida S] [Tokuno K] [Takashima M] [Ueno T] [Hinoda Y] [Oka M]
